Smoking, humoral immunity, and ulcerative colitis

Area of Science:

• Gastroenterology
• Immunology
• Microbiology

Background:

• Ulcerative colitis (UC) predominantly affects non-smokers and ex-smokers.
• The potential role of smoking in modulating the gut's immune response to luminal antigens is not fully understood.

Purpose of the Study:

• To investigate whether smoking influences the humoral immune response in the gut lumen of individuals with ulcerative colitis.
• To compare immune responses between smokers and non-smokers with and without UC.

Main Methods:

• Collected gut lavage fluid and serum from healthy non-smokers, and smokers and non-smokers with UC.
• Measured specific antibody concentrations (IgG, IgA, IgM) against gut antigens like Escherichia coli, Candida albicans, gliadin, ovalbumin, and beta lactoglobulin using ELISA.
• Quantified total IgG, IgA, and IgM in intestinal secretions and serum, as well as circulating antibodies to gut commensals.

Main Results:

• A significant reduction in intestinal IgA concentration was observed in smokers with UC compared to healthy non-smoking controls.
• No other significant differences in antibody concentrations were found between the study groups.
• Circulating antibody levels to gut commensals did not differ significantly across groups.

Conclusions:

• The findings do not support the hypothesis that smoking suppresses immune responses within the gut.
• The observed reduction in intestinal IgA in UC smokers suggests that smoking's effect on colitis may involve mechanisms other than general immune suppression in the gut lumen.